A
- Aggregation
- The clumping of peptide molecules into insoluble assemblies, usually triggered by agitation, heat, freeze-thaw cycles, or a pH near the peptide’s isoelectric point. Aggregated peptide is no longer reliably usable in research.
- Agonist
- A molecule that binds a receptor and activates it, producing a response similar to the receptor’s natural ligand. Most research peptides catalogued here are agonists at a specific receptor.
- Amino Acid
- The building-block molecule of peptides and proteins; chains of amino acids linked by peptide bonds form peptides.
- Amino Acid Sequence
- The ordered list of amino acid residues that defines a peptide, conventionally written N-terminus to C-terminus using one- or three-letter codes. The sequence determines the molecule’s identity.
- Analog
- A compound structurally derived from a parent molecule with deliberate modifications — typically to extend half-life, improve stability, or alter receptor selectivity. Semaglutide is an analog of native GLP-1.
- Antagonist
- A molecule that binds a receptor without activating it, blocking the natural ligand from doing so. An antagonist produces no signal itself; its effect is the absence of one.
B
- BAC Water
- Bacteriostatic water — sterile water containing 0.9% benzyl alcohol, used in research to reconstitute lyophilized peptides.
- Benzyl Alcohol
- The bacteriostatic preservative present at 0.9% in bacteriostatic water. It inhibits bacterial growth, which is what permits a reconstituted vial to be drawn from more than once.
- Bioavailability
- The proportion of an administered compound that reaches systemic circulation intact. Peptides generally have very poor oral bioavailability because digestive enzymes cleave peptide bonds.
- Blend
- A supplier preparation combining two or more compounds in a single vial. Blends are convenient but fix the ratio between components, which removes a variable a researcher might otherwise want to control.
C
- C-Terminus
- The end of a peptide chain terminating in a free carboxyl group. Sequences are conventionally written ending at the C-terminus. Compare N-terminus.
- Chromatogram
- The output plot of an HPLC run, showing detector response against retention time. The main peak represents the target peptide; the area of the surrounding peaks is what a purity percentage actually summarises.
- COA
- Certificate of Analysis — a third-party document verifying a peptide's purity, identity, and composition, usually determined by HPLC or mass spectrometry.
- Cyclic Peptide
- A peptide whose chain forms a ring, typically through a disulfide bridge or a head-to-tail bond. Cyclisation usually increases resistance to enzymatic degradation relative to the linear form.
D
- Degradation
- Loss of a peptide’s intact structure over time through hydrolysis, oxidation, enzymatic cleavage, or aggregation. Temperature, light, pH, and time in solution are the main drivers.
- Denaturation
- The loss of a peptide or protein’s three-dimensional structure while its sequence remains intact. Because activity depends on shape, denatured material is generally inactive. Shaking, heat, and extreme pH all cause it.
- Diluent
- The liquid used to dissolve a lyophilised compound. Bacteriostatic water is the most common diluent for research peptides; 1% acetic acid is used for sequences with poor neutral-pH solubility.
- Disulfide Bond
- A covalent bond between two cysteine residues that locks part of a peptide into a fixed conformation. Reducing agents break disulfide bonds and can inactivate peptides that depend on them.
- Downregulation
- A cell’s reduction in receptor number or sensitivity in response to sustained stimulation. It is why continuous receptor agonism can produce the opposite downstream effect to pulsatile stimulation of the same receptor.
E
- ELISA
- Enzyme-Linked Immunosorbent Assay — an antibody-based method for detecting and quantifying a specific peptide in a sample. Used in research to measure concentration, distinct from HPLC’s purity role.
- Endogenous
- Produced naturally within an organism, as opposed to introduced externally.
- Enzymatic Cleavage
- The breaking of a peptide bond by a protease enzyme. It is the principal route by which peptides are cleared in biological systems and the reason most peptides have short half-lives.
- Excipient
- A non-active substance included in a lyophilised vial — commonly mannitol or a buffering salt — to protect the peptide during freeze-drying and aid redissolution. Excipients are listed on a thorough COA.
- Exogenous
- Originating from outside the body; for research peptides, this refers to the introduced compound.
- Extracellular Matrix
- The network of collagen, elastin, glycosaminoglycans and other molecules surrounding cells in tissue. Several tissue-repair and dermal research peptides are studied for their effect on matrix composition.
F
- Freeze-Thaw Cycle
- One round of freezing and thawing a solution. Each cycle stresses peptide structure and promotes aggregation, which is why reconstituted material is refrigerated rather than repeatedly frozen.
G
- GHRH
- Growth Hormone-Releasing Hormone — the hypothalamic peptide that stimulates pituitary growth hormone release. Sermorelin, CJC-1295 and Tesamorelin are GHRH analogs.
- GHRP
- Growth Hormone-Releasing Peptide — a class acting at the ghrelin receptor (GHS-R) rather than the GHRH receptor. Ipamorelin, Hexarelin, GHRP-2 and GHRP-6 belong to this class, which is why they are studied alongside but distinctly from GHRH analogs.
- Glycoprotein
- A protein carrying covalently attached carbohydrate chains. HCG is a glycoprotein hormone; the sugar component affects its stability and circulating half-life.
- Glycosaminoglycan
- A long unbranched polysaccharide, such as hyaluronic acid, that is a major structural component of the extracellular matrix. Frequently referenced in dermal and tissue-remodelling research.
- GMP
- Good Manufacturing Practice — a quality-assurance standard governing how products are produced, tested, and controlled.
- GnRH
- Gonadotropin-Releasing Hormone — the hypothalamic decapeptide that triggers pituitary release of LH and FSH. Gonadorelin is synthetic GnRH; Triptorelin is a longer-acting GnRH agonist.
- Gonadotropin
- A hormone acting on the gonads, principally LH and FSH. HCG acts at the LH receptor; HMG supplies both FSH and LH activity.
H
- Half-Life
- The time required for a substance's concentration to decrease by half under physiological conditions.
- HPG Axis
- The Hypothalamic-Pituitary-Gonadal axis — the feedback loop running hypothalamus (GnRH) to pituitary (LH/FSH) to gonads. Most compounds in the hormonal category act at one identifiable point along it.
- HPLC
- High-Performance Liquid Chromatography — the gold-standard analytical method for determining peptide purity.
- Hydrolysis
- Cleavage of a chemical bond by water. Peptide bonds hydrolyse slowly in aqueous solution, which is the fundamental reason lyophilised powder is more stable than reconstituted solution.
I
- In Vitro
- Latin for "in glass" — research conducted outside a living organism, in cell culture or a test tube. The research-use designation on these compounds refers to in-vitro and preclinical laboratory work.
- In Vivo
- Research conducted within a living organism. In peptide research literature this most often refers to animal models rather than human studies.
- Incretin
- A gut hormone released after eating that stimulates insulin secretion. GLP-1 and GIP are the two principal incretins, and the GLP-1 family of research compounds are incretin-receptor agonists.
- Isoelectric Point
- The pH at which a peptide carries no net electrical charge. Solubility is at its minimum here and aggregation risk at its maximum, which is why solvent pH matters for some sequences.
L
- Ligand
- Any molecule that binds a receptor. An endogenous ligand is the body’s own; a research peptide studied at that receptor is an exogenous one.
- Lipolysis
- The metabolic breakdown of stored triglycerides into free fatty acids and glycerol. It is the process the GH-fragment research compounds AOD-9604 and HGH Fragment 176-191 are studied in relation to.
- Lot Number
- The identifier tying a specific production batch to its Certificate of Analysis. A COA that cannot be matched to the lot number on the vial in hand documents nothing about that vial.
- Lyophilized
- Freeze-dried. Peptides are typically shipped in lyophilized form to preserve stability during transport and storage.
M
- Mass Spectrometry
- An analytical method that measures a molecule’s mass-to-charge ratio, confirming that a peptide’s molecular weight matches its stated sequence. It answers identity; HPLC answers purity. Both are needed.
- Molecular Weight
- The mass of one molecule, reported in daltons (Da) or g/mol. For a peptide it is determined by its sequence, which is what allows mass spectrometry to confirm identity.
N
- N-Terminus
- The end of a peptide chain terminating in a free amino group. Sequences are conventionally written starting from the N-terminus. Compare C-terminus.
- Nootropic
- A descriptor for compounds studied for effects on cognition, memory, or neuroprotection. In this library it denotes a research category, not a claim about any compound’s effects.
P
- Peptide
- A short chain of amino acids (typically 2–50) linked by peptide bonds; longer chains are classified as proteins.
- Peptide Bond
- The covalent chemical bond that links one amino acid's carboxyl group to the next amino acid's amino group.
- Peptidomimetic
- A molecule designed to reproduce a peptide’s interaction with its target while differing in chemical structure, usually to gain resistance to enzymatic degradation. Adipotide is described as a peptidomimetic.
- Pharmaceutical Grade
- Material manufactured under regulatory requirements for human medicinal use, with the associated documentation and oversight. Research-grade material is not manufactured to this standard and is not a substitute for it.
- Potency
- The concentration or amount of a compound required to produce a given effect. Distinct from purity: highly pure material can be low-potency if it has partially degraded or misfolded.
- Protease
- An enzyme that cleaves peptide bonds. Proteases in blood and tissue are the principal reason unmodified peptides have short half-lives, and resistance to them is a common design goal for analogs.
- Pulsatile Secretion
- Hormone release in discrete bursts rather than continuously. Several endocrine axes respond to the pattern of stimulation as much as its magnitude, so a short-acting and a long-acting analog at the same receptor can produce opposite downstream effects.
- Purity
- The percentage of a sample that is the target compound, in research peptides conventionally determined by HPLC. A purity figure without a chromatogram is an unverifiable claim.
R
- Receptor
- A protein structure in a cell that binds specific signaling molecules, triggering a cellular response.
- Receptor Selectivity
- The degree to which a compound acts on its intended receptor rather than related ones. Low selectivity means effects attributable to off-target binding, which complicates interpretation of results.
- Reconstitution
- The process of dissolving a lyophilized peptide in a solvent (usually BAC water) to create a research-use solution.
- Research Grade
- A designation indicating a compound is intended solely for in-vitro laboratory research, not human or veterinary use.
- Residue
- A single amino acid within a peptide chain. Called a residue because forming each peptide bond releases a water molecule, leaving what remains of the free amino acid.
S
- Secretagogue
- A substance that stimulates secretion of another substance. Growth hormone secretagogues such as MK-677 and the GHRPs prompt endogenous GH release rather than supplying GH directly.
- Sequence Notation
- The convention for writing a peptide’s composition, using one-letter (A, G, K) or three-letter (Ala, Gly, Lys) amino acid codes, always ordered N-terminus to C-terminus.
- Shear Stress
- The mechanical force applied to molecules in a liquid by vigorous movement. Shaking a reconstituted vial subjects peptides to shear stress and can denature them, which is why swirling is the standard technique.
- Solubility
- The extent to which a compound dissolves in a given solvent. Peptides with a high proportion of hydrophobic residues may not dissolve fully in bacteriostatic water and require an acidic solvent instead.
- Stability
- A compound’s resistance to degradation under defined conditions of temperature, light, pH and time. Lyophilised peptides are far more stable than reconstituted ones; stability windows vary by compound.
- Sterile Water
- Purified water with no preservative. Suitable for single-use preparations only — unlike bacteriostatic water, it does not inhibit bacterial growth, so a vial reconstituted with it should not be drawn from repeatedly.
- Subcutaneous
- Administered under the skin; a common route referenced in peptide research literature.
- Synthesis
- The laboratory process of creating peptides, typically via solid-phase peptide synthesis (SPPS).
- Systemic
- Affecting the body as a whole via circulation, as opposed to acting locally at an application site. The distinction matters when reading dermal research, where topical and systemic contexts produce very different findings.
T
- Third-Party Testing
- Analysis performed by a laboratory independent of the supplier. A COA issued by the seller’s own lab carries materially less evidentiary weight than one from an independent facility.
- Topical
- Applied to the skin surface. For a topical peptide, penetration through the stratum corneum is itself a research variable, largely governed by molecular weight and lipophilicity.
- Tripeptide
- A peptide of exactly three amino acid residues. GHK-Cu and AHK-Cu are copper-binding tripeptides — among the smallest molecules in the library.
U
- Upregulation
- A cell’s increase in receptor number or sensitivity, typically in response to reduced stimulation. The counterpart to downregulation.
V
- Vasoactive
- Affecting the diameter of blood vessels and therefore blood flow. VIP (Vasoactive Intestinal Peptide) is named for this property.
- Vial
- The sealed glass container a research peptide ships in, typically holding lyophilised powder under vacuum or inert gas with a rubber septum for withdrawal without opening.
Keep reading
Peptide Directory
All 79 entries, by category and A–Z.
Research Library
Lab-verification methods, category hubs, and structured comparisons.
FAQ
Common questions on legality, purity standards, storage, and suppliers.